Shaping Life Sciences

The healthcare industry is facing increasing costs, evolving patient expectations, and a demand for better research and development, service models, and treatments.

To address these challenges, healthcare businesses need to adopt a modern transformation approach that incorporates digital technology at its core. By doing so, they can develop a reinvention strategy that drives future sustainable growth.

New Reality of Biopharma’s
The COVID-19 pandemic has changed the biopharma industry's economic environment and demands a shift towards embracing New Science as a growth source, reducing costs, and becoming future-fit.

Powerful Outcomes via R&D Optimization
The biopharma industry must reimagine R&D with digitally powered and patient-centric design using data, advanced analytics, and technology. We identified three plays powered by five enablers that can help businesses make this shift, reduce costs, adopt New Science, and change the pipelines to commercialization and access.

Digital Health in Medtech
MedTech companies are best positioned to lead the transformation in Digital Health. However, without the right digital foundation to support these companies internally, digital insights will be difficult to leverage to create a comprehensive Digital Health solution. We uncovered five key trends driving the future growth of MedTech.

New Paradigms for Sustainable Growth
The life sciences industry has a heavy reliance on mergers and acquisitions (M&A) for growth. We identified four pathways companies are taking to shift towards sustainable growth and the patterns behind it. Companies must choose the right roadmaps combined with three key actions to determine future growth, lasting impacts, and patient outcomes.

Taking Life Sciences to the Metaverse
The metaverse is evolving rapidly, with some components already creating revolutions in the life sciences industry. We found that 85% of Biopharma and 91% of MedTech executives consider it will have a positive impact on their organizations. Four key technology trends will create truly humanized digital approaches that will bring us closer to meeting the unmet needs of patients, employees, and healthcare professionals.

New pace of change

The biopharma industry is facing a new economic environment that demands change, as rising costs of New Science and patient care collide with slow technology adoption. The industry must produce and deliver effective, affordable, and personalized treatments while adapting to new ways of working at crisis pace.